C12Y 207/01037
Protein kinase
Official title: Protein kinase (2.7.1.37) (C12Y207/11001, C12Y207/11008 - C12Y207/11013, C12Y207/11021, C12Y207/11022, C12Y207/11024, C12Y207/11025, C12Y207/1103, C12Y207/12001 take precedence)
C12Y207/01037 (Protein kinase) appears on 87 US grants and 110 published applications in this corpus.
Search patents in C12Y- Granted patents
- 87
- Published applications
- 110
- Assignees
- 61
- Inventors
- 191
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 8 | 0 |
| 2001 | 10 | 0 |
| 2002 | 8 | 11 |
| 2003 | 7 | 18 |
| 2004 | 7 | 20 |
| 2005 | 4 | 21 |
| 2006 | 8 | 5 |
| 2007 | 7 | 2 |
| 2008 | 4 | 4 |
| 2009 | 6 | 3 |
| 2010 | 1 | 5 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 3 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 3 | 1 |
| 2023 | 1 | 4 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Regulation of RAN translation by PKR and eIF2α-P pathways18 Nov 2025US 12,473,545 B2University of Florida Research Foundation, Inc.
- Fungal resistant plants expressing RLK125 Jul 2023US 11,708,583 B2BASF Plant Science GmbH
- Cyclic GMP-chelating peptides for subcellular targeting29 Nov 2022US 11,512,294 B2Centre National De La Recharche Scientifique
- Regulation of RAN translation by PKR and eIF2A-P pathways31 May 2022US 11,345,911 B2University of Florida Research Foundation, Inc.
- Inhibition of MAP4K4 through RNAi22 Feb 2022US 11,254,940 B2Phio Pharmaceuticals Corp.
- Regulation of ran translation by pkr and eif2a-p pathways16 Apr 2026US 2026/0103700 A1University of Florida Research Foundation, Inc.
- Compositions and methods for regulating t cells7 Dec 2023US 2023/0392117 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Small molecule modulators of ksr-bound mek30 Nov 2023US 2023/0381180 A1Icahn School of Medicine at Mount Sinai
- Use of cops3 inhibitors for treating hepatitis b virus infection20 Apr 2023US 2023/0122751 A1Hoffmann-La Roche Inc.
- Regulation of ran translation by pkr and eif2a-p pathways5 Jan 2023US 2023/0002753 A1University of Florida Research Foundation, Inc.
Most cited
By later US patents
- Determining prognosis of colon or breast cancer by measuring TTK expression81US 7,501,244 B2Novartis Vaccines and Diagnostics, Inc. · 2009
- Oligoribonucleotides with enzymatic activity72US 6,617,438 B1Sirna Therapeutics, Inc. · 2003
- PSKH-1 ribozymes62US 5,856,463 A1999
- Synthetic ribonucleic acids with RNAse activity56US 6,528,640 B1Ribozyme Pharmaceuticals, Inc. · 2003
- Inhibition of MAP4K4 through RNAI52US 9,074,211 B2RXi Pharmaceuticals Corporation · 2015